SG Americas Securities
ORKA

SG Americas Securities’s Oruka Therapeutics ORKA Stock Holding History

SG Americas Securities’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
+14,576
New +$971K ﹤0.01% 1685
2026
Q1 		– Sell
-8,275
Closed -$251K – 3795
2025
Q4 		$251K Buy
+8,275
New +$231K ﹤0.01% 2838

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SG Americas Securities's ORKA Position: Q2 2026 in Review

SG Americas Securities opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 14,576 shares worth $1.39M. The stake represents ﹤0.01% of the portfolio and ranks #1685 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in ORKA as recently as Q4 2025.

SG Americas Securities first reported a position in ORKA in Q4 2025 and has held it in 2 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • SG Americas Securities held 14,576 shares of Oruka Therapeutics worth $1.39M as of Q2 2026.
  • Oruka Therapeutics was a new SG Americas Securities position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1685 holding.
  • SG Americas Securities first reported a position in Oruka Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.